A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis. Kuhle J, Hardmeier M, Disanto G, Gugleta K, Ecsedi M, Lienert C, Amato MP, Baum K, Buttmann M, Bayas A, et al. Mult Scler. 2015 Sep 11. PMID: 26362898. Abstract CommentRecommendBookmarkWatch